Maria Carla Re

1.          Gibellini D, Borderi M, Bon I, Biagetti C, De Crignis E, Re MC. HIV-1 infection of a nurse from a newborn with an unknown HIV infection: a case report. J Clin Virol . 2009 Dec;46(4):374-7.

2.          Re MC , Vitone F, Biagetti C, Schiavone P, Alessandrini F, Bon I, de Crignis E, Gibellini D. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients. Clin Microbiol Infect . 2009 Sep 2.

3.          Zazzi M, Prosperi M, Vicenti I, Di Giambenedetto S, Callegaro A, Bruzzone B, Baldanti F, Gonnelli A, Boeri E, Paolini E, Rusconi S, Giacometti A, Maggiolo F, Menzo S, De Luca A; ARCA Collaborative Group (Re MC) Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. J Antimicrob Chemother. 2009 Sep;64(3):616-24.

4.          Biagetti C, Bon I, Vitone F, Schiavone P, Borderi M, Pavoni M, Verucchi G,Re MC, Chiodo F.Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection.New Microbiol. 2009 Apr;32(2):129-34

5.          Borderi M, Gibellini D, Vescini F, De Crignis E, Cimatti L, Biagetti C, Tampellini L, Re MC Metabolic bone disease in HIV infection. AIDS. 2009 Jul 17;23(11):1297-310.

6.          Buonaguro L, Petrizzo A, Tagliamonte M, Vitone F,Re MC, Pilotti E, Casoli C, Sbreglia C, Perrella O, Tornesello ML, Buonaguro FM. Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy.Infect Agent Cancer. 2008 Oct 10;3:13.

 

7.          Gibellini D, De Crignis E, Ponti C, Cimatti L, Borderi M, Tschon M, Giardino R, Re MC. HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. J Med Virol. 2008 Sep;80(9):1507-14

8.          La Placa M, Vitone F, Volpi W, Caproni M, Gibellini D, Torchia D, Fabbri P, Re MC Detection of serum antibodies to human intracisternal A-type retroviral particles in chronic idiopathic urticaria. J Eur Acad Dermatol Venereol. 2009 Mar;23(3):352-3.

9.          De Crignis E, Cimatti L, Borderi M, Gibellini D, Re MC. Bone alterations during HIV infection.New Microbiol. 2008 Apr;31(2):155-64. Review

10.      Re MC, Schiavone P, Vitone F, Bon I, De Crignis E, Biagetti C, Alessandrini F, Gibellini D. Low avidity antibody: a reliable method to diagnose a recent HIV-1 infection.New Microbiol. 2008 Jan;31(1):19-26

11.      Gibellini D, Borderi M, De Crignis E, Cicola R, Cimatti L, Vitone F, Chiodo F, Re MC.HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals.J Infect. 2008 Mar;56(3):219-25.

12.     Bon I, Gibellini D, Borderi M, Alessandrini F, Vitone F, Schiavone P, Re MC. Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients.J Clin Virol. 2007 Apr;38(4):313-20.

13.      Pilotti E, Elviri L, Vicenzi E, Bertazzoni U, Re MC, Allibardi S, Poli G, Casoli C. Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication.Blood. 2007 Mar 1;109(5):1850-6.

14.      Gibellini D, Vitone F, Buzzi M, Schiavone P, De Crignis E, Cicola R, Conte R, Ponti C, Re MC. HIV-1 negatively affects the survival/maturation of cord blood CD34(+) hematopoietic progenitor cells differentiated towards megakaryocytic lineage by HIV-1 gp120/CD4 membrane interaction.J Cell Physiol. 2007 Feb;210(2):315-24. 5.

15.   La Sala GB, Pilotti E, Nicoli A, Pinelli S, Villani MT, Ronzi P, Zendri E, Re MC, Magnani G, Casoli C. Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures.AIDS. 2007 Jan 30;21(3):377-9.

16.   Gibellini D, Borderi M, De Crignis E, Cicola R, Vescini F, Caudarella R, Chiodo F, Re MC. RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men. J Med Virol. 2007 Oct;79(10):1446-54. 7.

17.   Bon I, Alessandrini F, Borderi M, Gorini R, Re MC. Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management. New Microbiol. 2007 Jul;30(3):313-7.

18.   Vitone F, Gibellini D, Schiavone P, D'Antuono A, Gianni L, Bon I, Re MC. Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results. BMC Infect Dis. 2006 Mar 2;6:41.

19.   Gibellini D, Gardini F, Vitone F, Schiavone P, Furlini G, Re MC Simultaneous detection of HCV and HIV-1 by SYBR Green real time multiplex RT-PCR technique in plasma samples. Mol Cell Probes. 2006 Jun-Aug;20(3-4):223-9.

20.   Re MC , Vitone F, Bon I, Schiavone P, Gibellini D. Meaning of DNA detection during the follow-up of HIV-1 infected patients: a brief review. New Microbiol. 2006 Apr;29(2):81-8. Review.

21.   Gibellini D, Re MC, Ponti C, Vitone F, Bon I, Fabbri G, Grazia Di Iasio M, Zauli G. HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: a potential molecular mechanism to escape TRAIL cytotoxicity.J Cell Physiol. 2005 Jun;203(3):547-56.

22.   Re MC , Bon I, Schiavone P, Vitone F, Gibellini D. Discordant resistance interpretations in multi-treated HIV-1 patients. Int J Antimicrob Agents. 2005 Mar;25(3):211-5.

23.   Vitone F, Gibellini D, Schiavone P, Re MC. Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy. J Clin Virol. 2005 Jul;33(3):194-200. Epub 2004 Dec 15.

24.   Gibellini D, Vitone F, Schiavone P, Re MC. HIV-1 tat protein and cell proliferation and survival: a brief review. New Microbiol. 2005 Apr;28(2):95-109. Review.

25.   Re MC Vitone F, Sighinolfi L, Schiavone P, Ghinelli F, Gibellini D. Different patterns of HIV-1 DNA after therapy discontinuation.BMC Infect Dis. 2005 Sep 12;5:69.

26.   Gibellini D, Vitone F, Gori E, La Placa M, Re MC. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients. 17. J Virol Methods. 2004 Feb;115(2):183-9.

27.   Re MC , Monari P, Bon I, Borderi M, Chiodo F; HIV-1 Emilia Romagna Infectious Disease Study Group. Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naïve HIV-1 patients with acute and chronic infection. Int J Antimicrob Agents. 2004 Feb;23(2):164-8.

28.   Gibellini D, Vitone F, Schiavone P, Ponti C, La Placa M,Re MC. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. J Clin Virol. 2004 Apr;29(4):282-9.

29.   Re MC , Gianni L, Sassi M, Monari P, Imola M, La Placa M, Gibellini D. An imported case of adult T cell leukemia in a HTLV-I-infected patient in Italy. New Microbiol. 2004 Apr;27(2):183-6.

30.   La Placa M, Bianchi T, Vitone F, Muratori L, Varotti C, Gibellini D, Re MC. Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients. Acta Derm Venereol. 2004;84(3):177-80.

31.   La Placa M, Vitone F, Bianchi T, Vincenzi C, Gibellini D, Re MC, Tosti A. Serum antibodies against human intracisternal A-type particle (HIAP) endogenous retrovirus in Alopecia areata patients: a hallmark of autoimmune disease? J Invest Dermatol. 2004 Aug;123(2):407-9.

32.   Re MC , Bon I, Monari P, Gorini R, Schiavone P, Gibellini D, La Placa M. Drug failure during HIV-1 treatment. New perspectives in monitoring drug resistance.New Microbiol. 2003 Oct;26(4):405-13. Review.

33.   Re MC , Bon I, Monari P, Borderi M, Gibellini D, Schiavone P, Vitone F, Chiodo F, La Placa M. Mutation patterns of the reverse transcriptase genes in HIV-1 infected patients receiving combinations of nucleoside and non nucleoside inhibitors. Int J Antimicrob Agents. 2003 Oct;22(4):388-94.

34.   Gibellini D, Monari P, Sassi M,Re MC. A rapid hemi-nested PCR for HTLV-I detection. J Clin Virol. 2003 Dec;28(3):341-3.

35.   Calza L, Borderi M, Farneti B, Tampellini L, Re MC, Monari P, Bon I, Chiodo F. Prevalence and virologic consequences of HIV-1 genotype mutations detected in a cohort of 161 Italian patients receiving a nelfinavir-based highly active antiretroviral therapy. J Chemother. 2003 Apr;15(2):165-72.

36.   Gibellini D, Re MC, Vitone F, Rizzo N, Maldini C, La Placa M, Zauli G. Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein. Clin Exp Immunol. 2003 Mar;131(3):428-35.

37.   Gibellini D, Re MC , La Placa M, Zauli G . Differentially expressed genes in HIV-1 tat-expressing CD4(+) T-cell line. Virus Res. 2002 Dec;90(1-2):337-45.

38.   Re MC , Monari P, Bon I, Borderi M, Gibellini D, Schiavone P, Vitone F, Furlini G, La Placa M. Development of drug resistance in HIV-1 patients receiving a combination of stavudine, lamivudine and efavirenz. Int J Antimicrob Agents. 2002 Sep;20(3):223-6.

39.   Re MC , Borderi M, Monari p, Bon I, Gorini R, Gibellini D, Fortunato L, Chiodo F, La Placa M. Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a cohort of Italian HIV-1 seropositive patients extensively treated with antiretroviral drugs. Int J Antimicrob Agents. 2001 Dec;18(6):519-23.

40.   Re MC , Monari P, Bon I, Gibellini D, Vitone F, Borderi M, La Placa M . Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients. BMC Microbiol. 2001;1:30. 

41.   Re MC , Gibellini D, Furlini G, Vignoli M, Vitone F, Bon I, La Placa M Relationships between the presence of anti-Tat antibody, DNA and RNA viral load. New Microbiol. 2001 Jul;24(3):207-15.

42.   Re MC , Monari P, Borderi M, Tadolini M, Verrucchi G, Vitone F, Spinosa S, la Placa M. Presence of genotypic resistance to antiretroviral drugs in a cohort of therapy-naive HIV-1-infected Italian patients. J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):315-6.

43.   Re MC, Gibellini D, Vitone F, La Placa M . Antibody to HIV-1 Tat protein, a key molecule in HIV-1 pathogenesis. A brief review.New Microbiol. 2001 Apr;24(2):197-205. Review.

44.   Gibellini D, Re MC , Ponti C, Celeghini C, Melloni E, La Placa M, Zauli G. Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells.Br J Haematol. 2001 Mar;112(3):663-70.

45.   Re MC , Vignoli M, Furlini G, Gibellini D, Colangeli V, Vitone F, La Placa M. Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients.J Clin Virol. 2001 Apr;21(1):81-9.

46.   Gibellini D, Re MC , Ponti C, Maldini C, Celeghini C, Cappellini A, La Placa M, Zauli G . HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand.Cell Immunol. 2001 Feb 1;207(2):89-99. 

47.   Re MC , Vignoli M, Furlini G.,Gibellini D.,Colangeli V., Ramazzotti E., La Placa M. Antibodies against full-length Tat protein and some low molecular weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients. J Clin Virol. 2001 Apr;21(1):81-9.

48.   Re MC ., Monari P., Gibellini D., Ciancianaini P., Dall'Aglio P.P., Vignoli M., Furlini G., Ramazzotti E., Bertazzoni U., Casoli C. Human T cell leukemia virus II increases telomerase activity in uninfected CD34+ Hematopoietic progenitor cells. In press: Journal of Hematotherapy. 2000 Aug;9(4):481-7.

49.   Gibellini D., Re MC., Miscia S., La Placa M , Zauli G. Extracellular Tat protein activates the transcriptional repressor ICER in both Jurkat cell line and primary peripheral blood mononuclear cells. In press AIDS, 2000.

50.   Re MC , Ramazzotti E., Manfredi R., Furlini G., Vignoli M, Maldini C., Borderi M., La Placa M. Viral load trend in HIV–1 seropositive patients with different CD4 cell counts before starting HAART. Journal of Clinical Virology, 2000, 17(1):5-11.

51.   Vignoli M., Furlini G., Re MC, Ramazzotti E., La Placa M: Modulation of CD4 CXCR4 and CCR5 makes human hematopoietic progenitor cell lines infected with human herpes virus 6 susceptible to Human immunodeficiency virus type 1. Journal of Hematotherapy, 2000, 9: 39-45

52.   Gibellini D, Bassini A, Re MC , Ponti C, Miscia S, Gonelli A, La Placa M, Zauli G. Stroma-derived factor 1alpha induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand. Br J Haematol. 2000 Nov;111(2):432-40.

53.   Gibellini D, Re MC, Bassini A, Guidotti L, Catani L, La Placa M, Zauli HIV-1 gp120 induces the activation of both c-fos and c-jun immediate-early genes in HEL megakaryocytic cells. British Journal of Haematology, 1999, 104:81-6.

54.   Suligoi B, Galli C., Ciuta S., Decker R., Albano F., D'Antuono A, Calabro G., Caprilli F., Donofrio P., Gaddoni G., Gentili F., Graifemberghi S., latino M.A., Maiello C., Manca N., Mignani L., Priamo L., Puiatti P., Re MC., Rossetti G., Scardigli F. Low Prevalence of HTLV-I and HTLV-II in patients with a sexually transmitted diseases. European Journal of Epidemiology, 1999, 15: 225-229.

55.   Aschbacher R, Monari P, Lolli S, Donzelli C, Colangeli V, Vignoli M, Ramazzotti E, Furlini G, Re MC: Evaluation of three different commercial procedures for quantifying human immunodeficiency virus type-1 RNA levels. New Microbiologica, 1999, 22:1-9

56.   Manfredi R, Borderi M, Re MC, Furlini G, Monari P, Spinosa Guzman SM, Tadolini M, Talo S, Donzelli C, Maldini C, Chiodo F A comparison of immunocomplex-dissociated serum HIV-1 p24 antigenemia and plasma HIV-1 viral load: assessment of 3,129 paired assays. New Microbiologica, 1999, 22: 269-75

57.   Re MC , Vignoli M, Furlini G, Ramazzotti E, Maldini C, La Placa M In a human lymphomyeloid progenitor cell line (KG-1) HIV-1 gp120 binds to chemokine-receptors CXC-R4 and CCR5, only in the presence of CD4. New Microbiologica,1999, 22: 365-8

58.   Casoli C., Re MC, Monari P., Furlini G., Tosi G., Gradozzi C., Dall'Aglio PP., Bertazzoni U., Accolla RS: Human T cell leukemia virus type II direcly acts on CD34+ hematopoietic precursors by increasing theirsurvival potential. Envelope associated HLA class II molecules reverse this effect. Blood, 1998, 91: 2296-2304

59.   Vignoli M., Stecca B., Furlini G., Re MC., Mantovani V., Zauli G., Visani G., Colangeli V., La Placa M: Impaired telomerase activity in uninfected hematopoietic progenitors in HIV-1-infected progenitors. AIDS , 1998 , 12: 999-1005

60.   Manfredi R., Monari P., Donzelli C., Furlini G.,Re MC, Chiodo F: Protease inhibitors in antivar therapy of pediatric HIV disease. Acta Pediatrica, 1998, 87: 814-816

61.   Re MC , Gibellini D., Aschbacher R., Vignoli M., Furlini G., Ramazzotti E., Bertolaso L., La Placa M High levels of HIV-1 replication show a clear correlation with downmodulation of BCL-2 protein in peripheral blood lymphocytes of HIV-1 seropositive subjects. Journal Medical Virology, 1998; 56: 6-73.

62.   Gibellini D., Re MC., Panaya R., Venturi E., Milani D., La Placa M., Zauli G.: Flow Cytometric quantification of HIV Tat protein in Tat-transfected Jurkat T cell lines. Journal of Immunological Methods, 1998, 221:107-17

63.   Gibellini D, Zauli G, Re MC, Furlini G, La Placa M Flow cytometry in situ polymerase chain reaction as an innovative approach to HIV-1 proviral DNA detection. European Journal of Histochemestry 1998, 42:137-41.

64.   Manfredi R., Monari P., Donzelli C., Furlini G.,Re MC, Chiodo F: Terapia antiretrovirale con gli inibitori della proteasi in associazione con gli inibitori della trascrittasi inversa in età peditrica: esperienza preliminare. Giornale Italiano delle Malattie Infettive, 1997, 3, S186.

65.   Malorni W., Guiducci G., Pasquinelli G., Rivabene R., Re MC., Ramazzotti E., De Luca M., La Placa M., Cenacchi G: HIV type 1 induces specific cyoskeleton alterations in human epithelial cells in culture. European Journal of Dermatology, 1997, 7: 263-269.

66.   Gibellini D, Re MC, Furlini G, La Placa M: Flow cytometry analysis of an in situ polymerase chain reaction (in situ PCR) for the detection of human immunodeficiency virus type-1 (HIV-1) proviral DNA". Methods in Molecular Biology", Protocols for PRINS and in situ PCR. Edited by J.R. Gosden, Humana Press Inc., Totowa, NJ, U.S.A. 1997, 71: 113-122.

67.   La Placa M, Re MC, Furlini G: Pathogenetic mechanisms of HIV-1-related alterations of hematopoiesis. In: "HIV and Cytokines" Guenounou, M. Ed., INSERM (Focus Series), 1997, 239-245.

68.   Re MC , Furlini G, Vignoli M, Ramazzotti E, Zauli G, La Placa M: Antibody against human immunodeficiency virus type-1 (HIV-1) Tat protein may have inflenced the progression of AIDS in HIV-1 infected hemophiliac patients. Clinical and Diagnostic Laboratory Immunology, 1996, 3: 230-232.

69.   Zauli G, Catani L, Gibellini D, Re MC, Vianelli N, Colangeli V, Capitani S, La Placa M: Impaired survival of bone marrow GPIIb/IIIa+ magakaryocytic cells as an additional pathogenetic mechanism of HIV-1 related thrombocytopenia. British Journal of Hematology, 1996, 92: 711-717.

70.   Cenacchi G, Guiducci G, Pasquinelli, Re MC, Ramazzotti E, Furlini G, Malorni W, De Luca M, Martinelli GN: Early ultrastructural changes of human keratinocytes after HIV-1 contact: an in vitro study. European Journal of Dermatology, 1996, 6: 213-218.

71.   Ramazzotti E, Vignoli M, Re MC, Furlini G, La Placa M: The enhanced NF- k B activation induced by TNF- a in stably tat-transfected cells is associated with the presence of cell surface-bound Tat protein. AIDS, 1996, 10: 455-461.

72.   Furlini G, Vignoli M, Ramazzotti E, Re MC, La Placa M: A concurrent human herpesvirus-6 (HHV-6) infection renders two human hematopoietic progenitor (TF-1 and KG-1) cell lines susceptible to human immunodeficiency virus type-1 (HIV-1) infection. Blood, 1996, 87: 4737-4745.

73.   Ansaloni L, Acaye GL, Re MC: High HIV seroprevalence among patients with pyomyosits in northen Uganda. Tropical Medicine and International Health, 1996, 1: 210-212

74.   Furlini G, Re MC, Vignoli M, Ramazzotti E, Monari P, La Placa M: The lack of susceptibility to HIV-1 infection in human hematopoietic progenitor TF-1 cell line correlates with the absence of LFA-1 (CD11a) surface adhesion molecule. Microbiologica 1995, 18: 59-67.

75.   Ramazzotti E, Marconi A, Re MC, Girolomoni G, Cenacchi G, Vignoli M, Zambruno G, Furlini G, La Placa M, Giannetti A: In vitro infection of human epidermal Langerhans' cells with HIV-1. Immunology, 1995, 85: 94-98.

76.   Gibellini D, Zauli G, Re MC, Furlini G, Lolli S, Bassini A, Celeghini C, La Placa M: In situ polymerase chain reaction technique revealed by flow cytometry as a tool for gene detection. Analytical Biochemistry, 1995, 228: 252-258.

77.   Zauli G, La Placa M, Vignoli M, Re MC, Gibellini D, Furlini G, Milani D, Marchisio M, Mazzoni M, Capitani S: An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. Journal of Acquired Immunodeficiency Syndromes and Human Retrovirology 1995, 10: 306-316.

78.   Re MC , Furlini G, Vignoli M, Ramazzotti E, Roderigo G, De Rosa V, Zauli G, Lolli S, Capitani S, La Placa M: Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. Journal of Acquired Immunodeficiency Syndromes and Human Retrovirology 1995, 10: 408-416.

79.   Zauli G, Catani L, Gibellini D, Re MC, Milani D, Borgatti P, Bassini A, La Placa M, Capitani S: The CD4 receptor plays essential but distinct roles in HIV-1 infection and induction of apoptosis in primary bone marrow GPIIb/IIIa+ megakaryocytes and the HEL cell line. British Journal of Haemathology, 1995, 91: 290-298.

80.   Zauli G, Furlini G, Vitale M, Re MC, Gibellini D, Zamai L, Visani G, Borgatti P, Capitani S, La Placa M: A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high affinity receptor for human immunodeficiency virus-type 1. Blood, 1994, 84: 1896-1905.

81.   Gibellini D, Zauli G, Re MC, Milani D, Furlini G, Caramelli E, Capitani S, La Placa M: Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-ß1 mRNA expression and protein synthesis in peripheral blood monocytes. British Journal of Haematology, 1994, 88: 261-267.

82.   Re MC , Furlini G, Gibellini D, Vignoli M, Ramazzotti E, Lolli S, Ranieri S, La Placa M: Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by a newly developed flow cytometry analysis of the product of an in situ PCR assay. Journal of Clinical Microbiology, 1994, 32: 2152-2157.

83.   Re MC , Furlini G, Zauli G, La Placa M: Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells. Brief review. Archives of Virology, 1994, 137: 1-23.

84.   Lazzarotto T, Campisi B, Re MC, Albertini F, Furlini G, Dalla Casa B, Landini MP: An in vivo study on active cytomegalovirus infection in relation to active HIV replication in HIV-I infected drug addicts. Journal of Infection 1994, 28: 287-291.

85.   Lazzarotto T, Campisi B, Re MC, Dalla Casa B, Furlini G, Landini MP: Correlazione tra infezione attiva da citomegalovirus e replicazione di HIV-1. Uno studio in vivo in pazienti affetti da AIDS. Microbiologia Medica , 1994, 9: 193-195.

86.   Lazzarotto T, Furlini G, Re MC, Ramazzotti E, Campisi B, Landini MP: Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1. Archives of Virology, 1994, 135: 13-28.

87.   Tabucchi A, Carlicci F, Consolmagno E, Monari P, Re MC, Marinello E, Pizzichini M, Pagani R, Lai CY: Changes in nucleotide purine content in the lymphocyte subpopulations of patients infected with HIV. Clinica Chimica Acta, 1994, 225: 147-153.

88.   Guerra B., Bianchi S., Corazza F., Raise E., Re MC., Bovicelli L.: Clinical progression and immunological changes in human immunodeficiency virus type 1 infected mothers during pregnancy and after delivery. Italian Journal of Gynecology and Obstetrician 1994, 2: 35-38.

89.   Tabucchi A, Carlucci F, Monari P, Re MC, Furlini G, Bisozzi L, Consolmagno E, Pizzichini M, Leoncini R, Pagani R, Marinello E: Levels of free purine nucleotides in continuous T-cell lines infected with HIV-1. Biomedicine & Pharmacotherapy, 1993, 47: 207-211.

90.   Zauli G, Vitale M, Re MC, Furlini G, Zamai G, Falcieri E, Gibellini D, Visani G, Davis BR, Capitani S, La Placa M: In vitro exposure to human immunodeficiency virus type 1 (HIV-1) induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell line. Blood, 1994, 83: 167-175.

91.   Gibellini D, Zauli G, Re MC, Furlini G, Lolli S, Borgatti A, Capitani S, La Placa M: CD4 engagement by HIV-1 in TF-1 hematopoietic progenitor cells increases protein kinase C activity and reduces intracellular Ca2+ levels. Microbiologica, 1994, 17: 85-92.

92.   Furlini G, Vignoli M, Re MC, Gibellini D, Ramazzotti E, Zauli G, La Placa M: Human immunodeficiency virus type-1 interaction with the membrane of CD4+ cells induces the synthesis and the nuclear translocation of 70k heat-shock protein. Journal of General Virology, 1994, 75: 193-199.

93.   Tabucchi A, Carlucci F, Ramazzotti E, Re MC, Marinello E, Rubino M, Pagani R: Analysis of purine nucleotides in lymphocytes from healthy subjects and AIDS patients. Biomedicine & Pharmacotherapy, 1992, 46: 25-29.

94.   Re MC , Zauli G, Furlini G, Visani G, Ranieri S, Monari P, Ramazzotti E, La Placa M: The impaired number of circulating granulocyte/macrophage progenitors (CFU-GM) in human immunodeficiency virus-type 1 infected subjects correlates with an active HIV-1 replication. Archives of Virology, 1993, 129: 53-64.

95.   Re MC , Gorini R, Vignoli M: Diagnosi di infezione di HIV-1/2. Screening sierologico nei donatori di sangue. The Ligand Quarterly , 1993, 12:555-558.

96.   Musiani M, Azzi A, Zerbini M, Gibellini D,Venturoli S, Zakrzewska, Re MC, Gentilomi GA, Gallinella G, La Placa M: Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients. Journal of Medical Virology 1993, 40: 157-160.

97.   Zauli G,Re MC, Gugliotta L, Furlini G, La Placa M: The elevation of circulating platelets after IFN- therapy in HIV-1 seropositive thrombocytopenic patients correlates with increased plasma levels of IL-6. Microbiologica, 1993, 16: 27-34.

98.   Zauli G, Furlini G, Re MC, Milani D, Capitani S, La Placa M: Human immunodeficiency virus type 1 (HIV-1) Tat-protein stimulates the production of interleukin 6 (IL-6) by peripheral blood monocytes. Microbiologica, 1993, 16: 115-120.

99.   Re MC , Zauli G, Gibellini D, Furlini G, Ramazzotti E, Monari P, Ranieri S, Capitani S, La Placa M. Uninfected hematopoietic progenitor (CD34+) cells purified from the bone-marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS, 1993, 7: 1049-1055.

100.                       Re MC , Furlini G, Ramazzotti E, D'Antuono A, Vignoli M, La Placa M Jr, Monari P, Zauli G, La Placa M: Human T-lymphotropic virus type I (HTLV-I) provirus-related DNA sequences in peripheral blood mononuclear cells of a patient, in the absence of a definite serological positivity. Microbiologica, 1993, 16: 373-380.

101.                       Gentilomi G, Zerbini M, Musiani M, Gallinella G, Gibellini D, Venturoli S, Re MC, Pileri S, Finelli C, La Placa M: In situ detection of B19 DNA in bone marrow of immunodeficient patients using a digoxigenin-labelled probe. Molecular and Cellular Probes, 1993, 7: 19-24.

102.                       Davis BR, Zauli G, Cen D, Antao VP, Re MC, Visani G, La Placa M: Inhibition of hematopoietic stem/progenitor cells by human immunodeficiency virus type 1. The negative regulation of hematopoiesis: Annals of the New York Academy of Sciences, 1993, 229: 391-397.

103.                       Zauli G, Vitale M, Davi B, Re MC, Gibellini D, Capitani S, La Placa M: Human immunodeficiency virus type 1 triggers apoptotic cell death of progenitor (CD34+) cells. The negative regulation of hematopoiesis: Annals of the New York Academy of Sciences, 1993, 229: 401.

104.                       Tabucchi A, Carlucci F, Re MC, Furlini G, Consolmagno E, Leoncini R, Pizzichini M, Marinello E, Rubino M, Pagani R: The behavior of free purine nucleotides in lymphocytes infected with HIV-1. Biochimica and Biophysica Acta, 1993, 1182: 317-322.

105.                       Re MC , Furlini G, Ramazzotti E, Vignoli M, Zauli G, Lolli S, Monari P, Belletti D, Nanetti A, La Placa M: Absence of HTLV-I/II infection in blood donors with positive and inconclusive HTLV-I/II serology. Microbiologica, 1992, 15: 329-336.

106.                       Zauli G, Re MC, Sen L, Davis B, Visani G, Gugliotta L, Furlini G, La Placa M: Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in HIV-1 seropositive thrombocytopenic individuals. Blood, 1992, 79: 2680-2687.

107.                       Furlini G, Re MC, Ramazzotti E, Vignoli M, Zaccarelli D, Zauli G, La Placa M: Absence of human immunodeficiency virus type 1 infection in blood donors with doubtful serum reactivity by western blot analysis. Immunology and Infectious Diseases, 1992, 2: 157-160.

108.                       Re MC , Furlini G, Vignoli M, Zauli G, Dalla Casa P, Masi M, La Placa M: Immunoblotting analysis of IgA and IgM antibody to human immunodeficiency virus type 1 (HIV-1) polypeptides in seropositive infants. European Journal of Clinical Microbiology & Infectious Diseases, 1992, 11: 27- 32.

109.                       Zauli G, Re MC, Davis BR, Visani G, Furlini G, La Placa M: Tat protein stimulates production of Transforming Growth Factor-ß1 by marrow macrophages: A potential mechanism for HIV-1 induced hematopoietic suppression. Blood, 1992, 80: 3036-3043.

110.                       Zauli G, Re MC, Visani G, Furlini G, La Placa M: Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells. Archives of Virology, 1992, 122: 271-280.

111.                       Re MC , Zauli G, Furlini G, Vignoli M, Ramazzotti E, La Placa M: Hyperimmunoglobulinemia in HIV-1 infected individuals does not clearly correlate with plasma levels of IL-6. AIDS Research and Human Retroviruses, 1992, 8: 1289-1295.

112.                       Portincasa P, Conti G, Re MC, Chezzi C: Detection of IgA and IgM antibodies to HIV-1 in neonates by radioimmune Western blotting. British Medical Journal, 1992, 304: 1539-1542.

113.                       Mazza P, Bocchia M, Tumietto F, Costigliola P, Coronado O, Bandini G, Conte R, Ricchi E, Vianelli N, Raise E, Fondacaro A, Re MC, Vignoli M, Chodo F, Tura S: Recombinant interleukin 2 (rIL-2) in acquired immune deficiency syndrome (AIDS): preliminary reports in patients with lymphoma associated with HIV infection. European Journal of Hematology, 1992, 49: 1-6.

114.                       Zauli G, Re MC, Furlini G, Giovannini M, La Placa M: Human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp120-mediated killing of human hematopoietic progenitors (CD34+ cells). Journal of General Virology, 1992, 73: 417-421.

115.                       Re MC , Ramazzotti E, Vignoli M: HTLV-I: Aspetti epidemiologici e diagnosi d'infezione. Esa-System, 1992, 1: 24-28.

116.                       Carlucci F, Tabucchi A, Consolmagno E, Monari P, Re MC, Marinello E, Pagani R: Some aspects of purine metabolism in human peripheral blood lymphocytes. Nucleotide content in T-cells and not T-cells from healthy donors and HIV-1 positive patients. The Italian Journal of Biochemistry, 1992, 41: 273.

117.                       Re MC , Zauli G, Furlini G, Ranieri S, La Placa M: Progressive and selective impairment of IL-3 and IL-4 production by peripheral blood CD4+ T-lymphocytes during the course of HIV-1 infection. Viral Immunology, 1992, 5: 185-194.

118.                       Zauli G, Re MC, Visani G, Furlini G, Mazza P, Vignoli M, La Placa M. Evidence for a human immunodeficiency virus-type 1 mediated suppression of uninfected hematopoietic (CD34+) progenitor cells in AIDS patients. Journal of Infectious Diseases, 1992, 166: 710-716.

119.                       Re MC , Furlini G, Vignoli M, Ricchi E, Ramazzotti E, Bianchi S, Guerra B, Costigliola P, La Placa M: Vertical transmission of human immunodeficiency virus type 1: Prognostic value of IgA antibody to HIV-1 polypeptides during pregnancy. Diagnostic Microbiology and Infectious Diseases, 1992, 15: 553-556.

120.                       Cenacchi G, Re MC, Preda P, Pasquinelli G, Furlini G, Apkaraian RP, La Placa M, Martinelli GN.: Human immunodeficiency virus type 1 (HIV-1) infection of endothelial cells in vitro: a virological, ultrastructural and immuno-cytochemical approach. Journal of Submicroscropic Cytology and Pathology, 1992, 24: 155-161.

121.                       Re MC , Zauli G, Furlini G, Giovannini M, Ranieri S, Ramazzotti E, Vignoli M, La Placa M: GM-CSF production by CD4+ T-lymphocytes is selectively impaired during the course of HIV-1 infection. A possible indication of a preferential lesion of a specific subset of peripheral blood CD4+ T-lymphocytes. Microbiologica, 1992, 15: 265-270.

122.                       Tabucchi A, Carlucci F, Marinello E, Re MC, Bisozzi L, Cacopardo F, Pagani R: Purine nucleotide content of lymphocytes from healthy subjects and asymptomatic HIV-1 seropositive patients. The Italian Journal of Medicine (Recenti Progressi in Medicina) 1991, 82: 581-584.

123.                       Zauli G, Re MC, Giovannini M, Bagnara GP, Furlini G, Ranieri S, La Placa M: Effect of human immunodeficiency virus type 1 on CD34+ cells. “The negative regulators of hematopoiesis”. Annals of the New York Academy of Sciences, 1991, 628: 273-278.

124.                       Pileri S, Gambacorta M, Gerdes J, Sabattini E, Gritti FM, Chiodo F, Raise E, Costigliola P, Gherlinzoni F, Baglioni P, Poggi S, Zucchini L, Re MC, Sommariva F, Bartoli A, Tazzari PL, Falini B: The role of the lymph node biopsy in HIV-positive patients. Acta Oncologica, 1991, 12: 141-154.

125.                       Furlini G, Re MC, La Placa M: Increased poly(ADP-ribose)polymerase activity in cells infected by human immunodeficiency virus type 1. Microbiologica,1991, 14: 141-148.

126.                       Re MC , Zauli G, Furlini G, Giovannini M, La Placa M: HIV-1 infection and hematologic picture. Microbiologica, 1991, 14: 165-176.

127.                       Tabucchi A, Carlucci F, Rubino M, Marinello E, Ramazzotti E, Re MC, Pagani R: La determinazione dei nucleotidi purinici nei linfociti di soggetti sani o affetti da AIDS. Giornale Italiano di Chimica Clinica, 1991, 16: 231-238.

128.                       Zauli G, Re MC, Furlini G, Giovannini M, La Placa M: Evidence for an HIV-1 mediated suppression of in vitro growth of enriched (CD34+) hematopoietic progenitors. Journal of Acquired Immunodeficiency Syndromes, 1991, 4: 1251-1253.

129.                       Re MC , Furlini G, Cenacchi G, Preda P, La Placa M: Human immunodeficiency virus type 1 infection of endothelial cells in vitro. Microbiologica, 1991, 14: 149-152.

130.                       Zauli G, Re MC, Gugliotta L, Vianelli L, Furlini G, La Placa M: Lack of compensatory megakaryocytopoiesis in HIV-1 seropositive thrombocytopenic individuals compared with immune thrombocytopenic purpura patients. AIDS, 1991, 5: 1345-1350.

131.                       Bagnara GP, Zauli G, Re MC, Furlini G, Giovannini M, Ranieri S, Brizzi MF, La Placa M: Impaired GM-CSF production by cultured light density mononuclear cells and T lymphocytes correlates with the number of circulating CFU-gm in HIV-1 seropositive subjects. International Journal of Cell Cloning, 1991, 9: 239-250.

132.                       Bandini G, Re MC, Rosti G, Belardinelli AR: HIV infection and bone-marrow transplantation. Lancet, 1991, 337: 1163-1164.

133.                       Pappalardo G, Sermasi G, Re MC, Furlini G, Pelotti S, Malferrari F: Identification of anti HIV-1 antibodies in bloodstains of various ages. International Journal of Legal Medicine, 1991, 104: 63-65.

134.                       La Placa M, Re MC, La Placa Mjr, Cevenini R: Sexually transmitted diseases: Advanced in Diagnostic Biotechnologies. A brief overview. Microbiologica, 1991, 14: 267-278.

135.                       Raise E, Gritti F, Schiattone L, Pulsatelli L, Procaccio L, Cicognani M, Martuzzi M, Re MC: Changes of HIV-1 viremia in AIDS and AIDS related complex (ARC) patients treated with zidovudine. Journal of Chemotherapy, 1991, 3: 431-433.

136.                       Lazzarotto T, Guan M X, Furlini G, Re MC, Ripalti A, Landini MP, La Placa M: Relationship between human immunodeficiency virus antigenemia and cytomegalovirus infection. Microbiologica, 1990, 13: 61-65.

137.                       Visani G, Re MC, Colombini R, Cenacchi AR, Tosi P, Furlini G, Sermasi G, Ricci P, Fogli M, Zucchelli P, Sacchi R, Tura S: Retrospective screening for HTLV I infections in 68 acute leukemic patients multiply transfused before 1985. Vox Sanguinis, 1990, 58: 67-68.

138.                       Furlini G, Re MC, Musiani M, Zerbini M, La Placa M: Enhancement of HIV-1 marker detection in cell cultures treated with mild heat-shock. Microbiologica, 1990, 13: 21-26.

139.                       Bagnara GP, Giovannini M, Zauli G, Re MC, Furlini G, La Placa M: Early loss of circulating hemopoietic progenitors in HIV-1 infected subjects. Journal of Experimental Hematology, 1990, 18: 426-430.

140.                       Cenacchi G, Re MC, Furlini G, La Placa M, Binetti G, Rapezzi C, Alampi G, Magnani B: Human immunodeficiency virus type 1 antigen detection in an endomyocardial biopsy: an immunomorphological study. Microbiologica,1990, 13: 145-149.

141.                       Re MC , Landini MP, Furlini G, Lazzarotto T, Ripalti A, La Placa M: Correlazione tra infezione attiva da Cytomegalovirus e da virus della immunodeficienza acquisita. Microbiologia Medica, 1990, 5: 42.

142.                       Mirri A, Rapezzi C, Iacopi F, Ortolani P, Binetti G, Fabbri M, Ortolani P, Zauli T, Pintori C, Baroni M, Cenacchi G, Re MC, Ferlini A, Chiodo F, Maresta A, Magnani B: Interessamento cardiaco in corso di infezione da HIV: studio prospettico policentrico, clinico ed ecocardiografico. Cardiologia , 1990, 53: 203-209.

143.                       Re MC , Furlini G, La Placa M: Pattern of antigenemia and antibody response in patients infected with human immunodeficiency virus (HIV) according to clinical state. Journal of Clinical Pathology, 1989, 42: 282-283.

144.                       Re MC , Tommaseo M, Furlini G, La Placa M: High prevalence of serum antibody against human T cell leukemia virus type 1 (HTLV-I) among the Bisman Asmat population (Indonesian New Guinea). AIDS Research and Human Retroviruses, 1989, 5: 551-554.

145.                       Landini MP, Mirolo G, Re MC, Ripalti A, La Placa M: Antibody reactivity to cytomegalovirus structural polypeptides in subclinical and clinical human immunodeficiency virus infections. European Journal of Clinical Microbiology & Infectious Diseases, 1989, 8: 159-163.

146.                       Visani G, Re MC, Colombini R, Cenacchi AR, Furlini G, Sermasi G, Tosi P, Rosti G, Russo D, Zuffa E, Cuppini A, Zucchelli P, Motta MR, Sacchi R, Tura S: Human immunodeficiency virus testing in acute leukemia patients transfused between 1978 and 1985: a retrospective study on 91 cases. Haematologica, 1989, 74: 371-373.

147.                       Re MC , Furlini G, La Placa M: Rapid detection of HIV-1 in clinical samples by co-culture with heat-shocked cells. Journal of Virological Methods, 1989, 26: 313-318.

148.                       Re MC , Landini MP: IgM to human cytomegalovirus: Comparison of two enzyme immunoassays and IgM reactivity to viral polypeptides detected by immunoblotting. Journal of Clinical and Laboratory Analysis, 1989, 3: 169-173.

149.                       Re MC , Furlini G: Utilizzazione di un vaccino privo di MBP (proteina basica della mielina) nella prevenzione dell'infezione rabica. Giornale di Malattie Infettive e Parassitarie, 1989, 41: 174-176.

150.                       Furlini G, Re MC, Dallacasa P, Ferranti G, La Placa M: Serum antibody pattern, antigenemia and virus isolation in infants born to mothers seropositive for human immunodeficiency virus type 1. Journal of Medical Virology, 1989, 28: 129-132.

151.                       Conte R, Giovanardi L, Tazzari PG, De Rosa V, Roderigo G, Re MC: Non-HLA lymphocytotoxic antibodies in HIV-seropositive and HIV-seronegative hemophiliacs. Vox Sanguinis, 1988, 54: 47-51.

152.                       Re MC , Furlini G, Baldassarri B, Chiodo F: Serological study of subjects with seroconversion to human immunodeficiency virus. European Journal of Clinical Microbiology & Infectious Diseases, 1988, 7:144-148.

153.                       Furlini G, Re MC, Bandini G, Albertazzi L, La Placa M: Antibody response to human immunodeficiency virus after infected bone marrow transplant. European Journal of Clinical Microbiology & Infectious Diseases, 1988, 7: 664-666.

154.                       Ricchi E, Costigliola P, Colangeli V, Verrucchi G, Gelati G, Re MC, Chiodo F: Il rischio infettivo negli omosessuali maschi: Studio epidemiologico e clinico. Giornale di Malattie Infettive e Parassitarie, 1987, 39: 69-70.

155.                       Titti F, Lazzarin A, Costigliola P, Oliva A, Nicoletti L, Negri G, Ricchi E, Donati E, Umberti Foppa U, Re MC, Verani P, Chiodo F, Rossi GB, Moroni M: Human immunodeficiency virus (HIV) seropositivity in intravenous (IV) drug abusers in three cities of Italy:(possible natural history of HIV-1 infection in IV drug addicts in Italy. Journal of Medical Virology , 1987, 23: 241-248.

156.                       Mirolo G, Landini MP, Baldassarri B, Re MC, Lazzarotto T, La Placa M: Relationship between antibody titers against to cytomegalovirus detected by enzyme immunoassay and titer to individual viral polypeptides studied by immunoblotting. Microbiologica, 1986, 9: 373-379.

157.                       Landini MP, Mirolo G, Coppolecchia P, Re MC, La Placa M: Serum antibodies to individual citomegalovirus structural polypeptides in renal transplant recipients during viral infection. Microbiology & Immunology, 1986, 30: 683-695.

158.                       Mirolo G, Baldassarri B, Ripalti A, Re MC, Clementi M, Manzin A, Landini MP: Antibody response to individual cytomegalovirus structural proteins in different groups of subjects. European Journal of Clinical Microbiology, 1986, 6: 207-210.

159.                       Re MC , Landini MP, Coppolecchia P, Furlini G, La Placa M: A 28,000 molecular weight human cytomegalovirus structural polypeptide studied by means of a specific monoclonal antibody. Journal of General Virology, 1985, 66: 2507-2511.

160.                       Landini MP, Re MC, Mirolo G, Baldassarri B, La Placa M: Human immune response to human cytomegalovirus structural polypeptides studied by immunoblotting. Journal of Medical Virology, 1985, 17: 303-311.

161.                       Re MC , Baldassarri B, Furlini G, Coppolecchia P, Landini MP: Detection of antibodies to Legionella pneumophila serogroup 1 by indirect immunofluorecence and enzyme linked immunosorbent assay. Bollettino Istituto Sieroterapico Milanese, 1984, 63: 136-139.

162.                       Re MC , Baldassarri B, Furlini G, Coppolecchia P, Landini MP: Legionnaires diseases in Northen Italy. European Journal of Clinical Microbiology, 1984, 2: 362-363.

163.                       Baldassarri B, Ripalti A, Coppolecchia P, Furlini G, Garavini P, Lazzarotto T, Re MC, Landini MP: Azione di inibitori della DNA-topoisomerasi II sulla replicazione di alcuni virus erpetici. Giornale di Malattie Infettive e Parassitarie, 1984, 36: 503-505.

164.                       Zappulla F, Re MC, Mazzanti L, Zanelli MG, Sandri S, Baldassarri B, Alonge C, Ragni I, Parisini O, Lucchi A: Valutazione della frequenza di mononucleosi infettiva e presenza di anticorpi nei confronti del virus di Epstein Barr nella casistica di un Reparto Pediatrico di medicina generale. Minerva Pediatrica, 1984, 36: 923-926.

165.                       Re MC , Gatti M, Callegari V, Comastri G: Isolamento colturale, tipizzazione sierologica e ricerca dell'antigene capsulare mediante elettrosineresi nello studio delle infezioni da Streptococcus pneumoniae. Giornale di Malattie Infettive e Parassitarie, 1984, 36: 351-353.

166.                       Landini MP, Re MC, Baldassarri B, Coppolecchia P, Furlini G, Garavini P, Ripalti A: Eventi replicativi del citomegalovirus umano e loro applicazioni diagnostiche. Giornale di Malattie Infettive e Parassitarie, 1984, 36: 495-502.

167.                       Furlini G, Coppolecchia P, Re MC, Landini MP: Murine Cytomegalovirus acute and persistent infection: relationship between humoral immune response and presence of the virus in various organs. In: "CMV: Pathogenesis and Prevention of human infection". S. A. Plotkin, S.Michelson, J. Pagano, F. Rapp Editors. March of Dines Birth Defect Foundation. Birth Defects: Original Article Series. Alan R. Liss, New York USA, 1984, 20: 405-407.

168.                       Giammanco G, Andreoni O, Re MC, Nastasi A, Salvo S, Geminiani S, Falcida A, Girardini G, Amato R: Indagine policentrica sulla resistenza agli antibiotici nei batteri gram-positivi e gram-negativi. Acta Meditteranea di Patologia Infettiva e Tropicale, 1983, 2: 69-83.

169.                       Furlini G, Coppolecchia P, Re MC, Baldassarri B, Ripalti A, Landini MP: In vivo effect of novobiocin on primary cytomegalovirus infection. Journal of Antimicrobial Chemotherapy , 1983, 12: 503-506.

170.                       Coppolecchia P, Furlini G, Re MC, Landini MP: Evolution of serum antibodies against different classes of murine cytomegalovirus-induced antigens and virus isolation following a primary infection. Microbiologica, 1983, 6: 175-179.

171.                       Landini MP, Re MC, Coppolecchia P: Comparison of the occurence of antibodies to human cytomegalovirus as demonstrated by complement fixation, enzyme linked immunosorbent assay and indirect immunofluorescence. Bollettino Istituto Sieroterapico Milanese, 1982, 61: 320-323.

172.                       Cevenini R, Donati M, Rumpianesi F, Re MC, Rosito P, Vecchi V, Mancini AF: Primary Epstein-Barr virus infection in children with malignant disorders. Effect of therapy on EBV-antibodies. Journal of Infection, 1982, 5: 73-79.

173.                       Mazzaracchio R, Re MC, Callegari V: Valutazione del metodo ELISA per la ricerca degli anticorpi per il virus della rosolia. Bollettino Istituto Sieroterapico Milanese, 1981, 1: 39-41.

174.                       Chiodo F, Bassi B, Verrucchi G, Mazzaracchio R, Re MC: Vaccinazione antimorbillosa (valutazione clinico-sperimentale). La Clinica Pediatrica, 1980, 62: 47-54.

175.                       Re MC , Mazzaracchio R: Valutazione del metodo ELISA per la ricerca di anticorpi anti-citomegalovirus. Quaderni Sclavo di Diagnostica, 1980, 16: 129-133.

176.                       Re MC , Mazzaracchio R, Nanetti A: Distribuzione degli anticorpi fissanti il complemento nei confronti del virus del morbillo in un campione di popolazione residente in Emilia-Romagna. Annali Sclavo, 1980, 22: 141-146.

177.                       Callegari V, Del Bufalo C, Re MC, De Benedictis E, Dal Pozzo MS: Efficacia di un vaccino anti-influenzale con virus vivo ed attenuato somministrato per via intranasale in pazienti broncopneumatici cronoci. Rivista di Patologia e Clinica della Tubercolosi e di Pneumologia. 1980, 51: 257-264.

178.                       Mazzaracchio R, Re MC, Nanetti A: Distribuzione degli anticorpi inibenti l'emoagglutinazione del virus della rosolia in un campione di popolazione adulta dell'Emilia Romagna. Annali Sclavo, 1980, 22: 136-140.

179.                       Re MC , Callegari V, Dal Pozzo S: Risultati di un esperimento di vaccinazione anti-infuenzale con virus vivo ed attenuato. Annali Sclavo, 1978, 20: 639-642.

180.                       Mazzaracchio R, Re MC, Silvi E, Anania F: Ricerca nel sangue del funicolo degli anticorpi contro il virus rubeolico, citomegalico, erpetico e il Toxoplasma gondii. Rivista Italiana di Ginecologia, 1978, 59: 243-248.

181.                       Fusaroli M, Catizone L, Fabbri A, Callegari V, Re MC, Rovinetti C, Beltrandi B: L'infezione da citomegalovirus nel paziente in emodialisi periodica. Minerva Nefrologica, 1978, 25: 327-329.

182.                       173 Mazzaracchio R, Re MC, Callegari V: Ricerca degli anticorpi contro il virus della rosolia mediante emolisi radiale in gel. Quaderni Sclavo di Diagnostica, 1977, 13: 404-408.